Literature DB >> 30301368

Advances in stem cell therapy for erectile dysfunction.

Serap Gur1,2, Asim B Abdel-Mageed1, Suresh C Sikka1, Wayne J G Hellstrom1.   

Abstract

INTRODUCTION: Stem cell (SC) application is a promising area of research in regenerative medicine, with the potential to treat, prevent, and cure disease. In recent years, the number of studies focusing on SCs for the treatment of erectile dysfunction (ED) and other sexual dysfunctions has increased significantly. AREAS COVERED: This review includes critical ED targets and preclinical studies, including the use of SCs and animal models in diabetes, aging, cavernous nerve injury, and Peyronie's disease. A literature search was performed on PubMed for English articles. EXPERT OPINION: Combination treatment offers better results than monotherapy to improve pathological changes in diabetic ED. Regenerative medicine is a promising approach for the maintenance of sexual health and erectile function later in life. Cavernous nerve regeneration and vascular recovery employing SC treatment may be focused on radical prostatectomy-induced ED. Notwithstanding, there are a number of hurdles to overcome before SC-based therapies for ED are considered in clinical settings. Paracrine action, not cellular differentiation, appears to be the principal mechanism of action underlying SC treatment of ED. Intracavernosal injection of a single SC type should be the choice protocol for future clinical trials.

Entities:  

Keywords:  Erectile dysfunction; aging; cavernous nerve injury; diabetic rat; stem cell

Mesh:

Year:  2018        PMID: 30301368     DOI: 10.1080/14712598.2018.1534955

Source DB:  PubMed          Journal:  Expert Opin Biol Ther        ISSN: 1471-2598            Impact factor:   4.388


  6 in total

Review 1.  Stem-cell therapy for erectile dysfunction: a review of clinical outcomes.

Authors:  Mingyue He; Ernst R von Schwarz
Journal:  Int J Impot Res       Date:  2020-04-29       Impact factor: 2.896

Review 2.  Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA).

Authors:  James L Liu; Kevin Y Chu; Andrew T Gabrielson; Run Wang; Landon Trost; Gregory Broderick; Kelvin Davies; Gerald Brock; John Mulhall; Ranjith Ramasamy; Trinity J Bivalacqua
Journal:  Sex Med       Date:  2021-05-14       Impact factor: 2.491

3.  Combined Transplantation of Adipose Tissue-Derived Stem Cells and Endothelial Progenitor Cells Improve Diabetic Erectile Dysfunction in a Rat Model.

Authors:  Qiyun Yang; Wanmei Chen; Chi Zhang; Yun Xie; Yong Gao; Cuncan Deng; Xiangzhou Sun; Guihua Liu; Chunhua Deng
Journal:  Stem Cells Int       Date:  2020-07-03       Impact factor: 5.443

Review 4.  Adipose Tissue-Derived Stem Cell Therapy for Cavernous Nerve Injury-Induced Erectile Dysfunction in the Rat Model: A Systematic Review and Meta-Analysis Using Methodological Quality Assessment.

Authors:  Hyo Jung Park; Hyunsuk Jeong; Yong Hyun Park; Hyeon Woo Yim; U-Syn Ha; Sung-Hoo Hong; Sae Woong Kim; Na Jin Kim; Ji Youl Lee
Journal:  Int J Stem Cells       Date:  2019-07-31       Impact factor: 2.500

5.  In vivo tracking on longer retention of transplanted myocardin gene-modified adipose-derived stem cells to improve erectile dysfunction in diabetic rats.

Authors:  Hai-Bo Zhang; Feng-Zhi Chen; Shu-Hua He; Yan-Bing Liang; Zhi-Qiang Wang; Li Wang; Ze-Rong Chen; Wei Ding; Shan-Chao Zhao; An-Yang Wei
Journal:  Stem Cell Res Ther       Date:  2019-07-16       Impact factor: 6.832

6.  Identification of Key microRNAs in Diabetes Mellitus Erectile Dysfunction Rats with Stem Cell Therapy by Bioinformatic Analysis of Deep Sequencing Data.

Authors:  Jiaqi Kang; Yuxuan Song; Zhexin Zhang; Shangren Wang; Yi Lu; Xiaoqiang Liu
Journal:  World J Mens Health       Date:  2022-01-02       Impact factor: 6.494

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.